G1 Pharma - Rasio nilai perusahaan marang dodolan GTHX

Simbol resmi perusahaan G1 Therapeutics Inc. (GTHX)

G1 Therapeutics, Inc. (GTHX) net income is supported by the licensing of bone marrow protective agents in Europe and Asia. The firm's EV/Sales multiple valuation demonstrates the impact of interest rates on business value, where shows the current level of this metric. Revenues are based on sales of the approved drug, while the development strategy relies on receiving royalties from major pharmaceutical manufacturers.

G1 Therapeutics (GTHX): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

G1 Therapeutics - rincian analitis lan metrik utama (GTHX)

- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:GTHX, G1 Pharma
Produk sing diprodhuksi g1therapeutics.com

This indicator compares the total enterprise value to sales volume, excluding the impact of leverage to identify the actual market premium per unit of revenue. Analyzing the enterprise value-to-revenue ratio allows for an assessment of the asset's overvaluation, given that the efficient hospital logistics of G1 Therapeutics, Inc. (GTHX) stabilize margins, transforming operational resilience into a foundation for long-term capitalization growth.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|CMRX: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCC|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales